ESR1 and schizophrenia: Moreover, it was observed that the administration of raloxifene, a selective estrogen receptor modulator, binds estrogen receptor alpha (ESR-α) [127], increased PFC activity during inhibition of response to negative words and was greater in patients with schizophrenia homozygous for ESR1 rs9340799 AA relative to G carriers [128].